PGA
CELG

Portland Global Advisors’s Celgene Corp CELG Stock Holding History

Portland Global Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,578
Closed -$230K – 103
2017
Q3 		$230K Hold
1,578
– – 0.09% 95
2017
Q2 		$205K Buy
+1,578
New +$193K 0.08% 96
2016
Q1 		– Sell
-1,706
Closed -$204K – 107
2015
Q4 		$204K Buy
+1,706
New +$197K 0.11% 103

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Portland Global Advisors's CELG Position: Q4 2017 in Review

Portland Global Advisors sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 1,578 shares — an estimated $230K sold.

Portland Global Advisors first reported a position in CELG in Q4 2015 and held it in 3 quarters. The position peaked at $230K in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Portland Global Advisors reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Portland Global Advisors sold 1,578 Celgene Corp shares in Q4 2017, an estimated $230K.
  • Portland Global Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 3 quarters.
  • Portland Global Advisors's Celgene Corp position peaked at $230K in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Portland Global Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.